Methods and devices to treat nasal airways

US8986301B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8986301-B2
Application numberUS-201314026922-A
CountryUS
Kind codeB2
Filing dateSep 13, 2013
Priority dateJun 13, 2012
Publication dateMar 24, 2015
Grant dateMar 24, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method is described for modifying at least one property of a tissue of or near a nasal valve of a nose, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway. The method may involve contacting a treatment element of a treatment device with the at least one tissue inside the nasal airway, with sufficient force to at least temporarily deform the at least one tissue, applying energy to, or removing energy from, the at least one tissue, using the treatment element, and removing the treatment element from the nostril.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of modifying at least one property of at least one tissue of or near a nasal valve of a nose, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway, the method comprising: contacting an elongate treatment element of a treatment device with the at least one tissue inside the nasal airway, with sufficient force to at least temporarily deform the at least one tissue; applying energy to the at least one tissue by transmitting radio frequency energy from a first row of electrodes to a second row of electrodes disposed vertically on the elongate treatment element; and removing the elongate treatment element from the nostril. 2. A method as in claim 1 , wherein the elongate treatment element has a convex shape, such that contacting the treatment element against the at least one tissue at least temporarily deforms the tissue into a concave shape. 3. A method as in claim 2 , wherein contacting the elongate treatment element with the tissue causes at least one protrusion on the treatment element to deform the tissue. 4. A method as in claim 1 , wherein applying energy further comprises applying energy in a form selected from the group consisting of ultrasound, microwave, heat, electrical, light and laser. 5. A method as in claim 4 , wherein applying energy comprises delivering radiofrequency energy to one or more electrodes of the elongate treatment element to locally heat the at least one tissue, wherein delivering radiofrequency energy while deforming the at least one tissue causes the tissue to change shape. 6. A method as in claim 1 , wherein the at least one tissue comprises nasal valve tissue. 7. A method as in claim 1 , wherein the at least one tissue comprises nasal mucosa at or near a junction of a pyriform aperture and a lower lateral cartilage. 8. A method as in claim 1 , wherein the at least one tissue comprises upper lateral cartilage. 9. A method as in claim 1 , further comprising removing energy from the at least one tissue using cryogenic therapy provided by the elongate treatment element. 10. A method as in claim 1 , wherein the energy is applied to or removed from the at least one tissue while the at least one tissue is deformed. 11. A method as in claim 1 , wherein the energy applied by the elongate treatment element is generated from a power source within the treatment device. 12. A method as in claim 1 , further comprising injecting a substance into the at least one tissue prior to applying the energy, wherein the applied energy affects the injected substance to help modify the property of the tissue. 13. A method as in claim 1 , further comprising applying a substance to the at least one tissue or to an outer surface of the nose before applying the energy. 14. A method as in claim 1 , wherein the at least one property of the at least one tissue is modified without reshaping the at least one tissue. 15. A method as in claim 1 , wherein modifying the at least one property comprises stiffening the at least one tissue, with or without reshaping it. 16. A method as in claim 1 , wherein the at least one tissue is selected from the group consisting of epithelium, cartilage, mucosa, sub-mucosa, muscle, ligament, tendon and skin. 17. A method as in claim 1 , further comprising cooling the at least one tissue and/or other tissues in or on the nose, before, during, or after applying the energy. 18. A method as in claim 1 , further comprising: measuring at least one parameter at or near the at least one tissue to be treated; and adjusting a level of energy application or removal, based on the measured parameter. 19. A method as in claim 18 , wherein the at least one parameter is selected from the group consisting of temperature and impedance. 20. A device for treating a patient's nasal airway by modifying at least one property of at least one tissue of or near a nasal valve of the airway, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway, the device comprising: an energy delivery member sized to be inserted into a nose and configured to deliver energy to tissues within the nose to modify the at least one property of the at least one tissue; comprising multiple protruding electrodes configured to at least temporarily deform nasal tissue; a shaft extending from the energy delivery member; and a handle attached to the shaft at an opposite end from the energy delivery member, wherein the handle includes a housing to hold a power source for providing energy to the energy delivery member, wherein the protruding electrodes comprise two rows of electrodes, wherein the energy delivery member comprises a bipolar radio frequency delivery member, and wherein radio frequency energy travels from one row of electrodes to the other row of electrodes. 21. A device as in claim 20 , wherein the energy delivery member has a contact surface with convex shape configured to at least temporarily create a concavity in nasal tissue. 22. A device as in claim 20 , wherein the energy delivery member has a contact surface with flat shape. 23. A device as in claim 20 , wherein the housing is configured to hold at least one battery. 24. A device as in claim 20 , further comprising at least one sensor configured to sense at least one of temperature or impedance in nasal tissue. 25. A device as in claim 24 , wherein the at least one sensor is attached to the device on or near the energy delivery member. 26. A device as in claim 20 , further comprising a tissue cooling member attached to the device at or near the energy delivery member.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8986301B2 cover?
A method is described for modifying at least one property of a tissue of or near a nasal valve of a nose, without using a surgical incision or an implant, to decrease airflow resistance or perceived airflow resistance in a nasal airway. The method may involve contacting a treatment element of a treatment device with the at least one tissue inside the nasal airway, with sufficient force to at le…
Who is the assignee on this patent?
Aerin Medical Inc, Aerin Medical Inc
What technology area does this patent fall under?
Primary CPC classification A61F5/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).